Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates

Journal of Antibiotics

Volumn 68, Issue 7, 2015, Pages 431-435

  Li, Guilian ^a   Zhang, Jingrui ^b   Guo, Qian ^c   Wei, Jianhao ^d   Jiang, Yi ^e   Zhao, Xiuqin ^a   Zhao, Li Li ^b   Liu, Zhiguang ^c   Lu, Jianxin ^e   Wan, Kanglin ^a,b  

^a National Institute for Communicable Disease Control and Prevention   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

^d Laboratory Gynecological and Obstetric Hospital in Shi Jiazhuang   (China)

^e SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CHLORPROMAZINE; PROTEIN BACA; PROTEIN DRRB; PROTEIN DRRC; PROTEIN EFPA; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; UNCLASSIFIED DRUG; VERAPAMIL; CARRIER PROTEIN; DNA DIRECTED RNA POLYMERASE; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; GENE EXPRESSION; GENE MUTATION; KNOCKOUT GENE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; ADULT; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MISSENSE MUTATION; MULTIDRUG RESISTANT TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84938340462     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2015.9     Document Type: Article

References (32)

1. WHO. Global tuberculosis report 2013 (2013
2. McClure, W. R. &Cech, C. L. On the mechanism of rifampicin inhibition of RNA synthesis. J. Biol. Chem. 253, 8949-8956 (1978
3. Somoskovi, A., Parsons, L. M. &Salfinger, M. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respir. Res. 2, 164-168 (2001
4. Gupta, A. K. et al. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs. Microb. Drug Resist. 16, 21-28 (2010
5. Louw, G. E. et al. A balancing act: efflux/influx in mycobacterial drug resistance. Antimicrob. Agents Chemother. 53, 3181-3189 (2009
6. Louw, G. E. et al. Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux. Am. J. Respir. Crit. Care Med. 184, 269-276 (2011
7. Srivastava, S. et al. Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol. J. Infect. Dis. 201, 1225-1231 (2010
8. Pasca, M.R.et al. Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 48, 3175-3178 (2004
9. Pang, Y. et al. Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 57, 893-900 (2013
10. WHO. Policy Guidance on Drug-susceptibility Testing (DST) of Second-line Antituberculosis Drugs (WHO/HTM/TB/2008.392), (World Health Organization: Geneva, 2008
11. World Health Organization. Updated interim critical concentrations for first-line and second-line DST (as for May 2012) (2012
12. Kamerbeek, J. et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35, 907-914 (1997
13. Wada, T., Iwamoto, T. &Maeda, S. Genetic diversity of the Mycobacterium tuberculosis Beijing family in East Asia revealed through refined population structure analysis. FEMS Microbiol. Lett. 291, 35-43 (2009
14. Leonard, B. et al. Inter- and intra-assay reproducibility of microplate Alamar blue assay results for isoniazid, rifampicin, ethambutol, streptomycin, ciprofloxacin, and capreomycin drug susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 46, 3526-3529 (2008
15. Rodrigues, L. et al. Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex. Infect. Genet. Evol. 12, 695-700 (2011
16. Livak, K. J. &Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408 (2001
17. Bustin, S. A. et al. MIQE precis: practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments. BMC. Mol. Biol. 11, 74 (2010
18. DeMarco, C. E. et al. Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob. Agents Chemother. 51, 3235-3239 (2007
19. Mokrousov, I. et al. Origin and primary dispersal of the Mycobacterium tuberculosis Beijing genotype: clues from human phylogeography. Genome Res. 15, 1357-1364 (2005
20. Kurepina, N. E. et al. Characterization of the phylogenetic distribution and chromosomal insertion sites of five IS6110 elements in Mycobacterium tuberculosis: non-random integration in the dnaA-dnaN region. Tuber. Lung Dis. 79, 31-42 (1998
21. Gupta, A. K. et al. Estimation of efflux mediated multi-drug resistance and its correlation with expression levels of two major efflux pumps in mycobacteria. J. Commun. Dis. 38, 246-254 (2006
22. Sun, H. et al. Chronic inhibition of cardiac Kir2.1 and HERG potassium channels by celastrol with dual effects on both ion conductivity and protein trafficking. J. Biol. Chem. 281, 5877-5884 (2006
23. Tolon, R. et al. Potassium depolarization-induced cAMP stimulates somatostatin mRNA levels in cultured diencephalic neurons. Brain Res. 868, 338-346 (2000
24. Banerjee, S. K. et al. Involvement of an efflux system in mediating high level of fluoroquinolone resistance in Mycobacterium smegmatis. Biochem. Biophys. Res Commun. 226, 362-368 (1996
25. Choudhuri, B. S. et al. Overexpression and functional characterization of an ABC (ATPbinding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis. Biochem. J. 367, 279-285 (2002
26. Wilson, M. et al. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc. Natl Acad. Sci. USA 96, 12833-12838 (1999
27. Waddell, S. J. et al. The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds. Tuberculosis (Edinb) 84, 263-274 (2004
28. Cole, S. T. et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544 (1998
29. De Rossi, E. et al. The multidrug transporters belonging to major facilitator superfamily in Mycobacterium tuberculosis. Mol. Med. 8, 714-724 (2002
30. TubercuList [Internet]. Accessed 2010 Nov 15. http://genolist.pasteur.fr/TubercuList.
31. De Rossi, E., Ainsa, J. A. &Riccardi, G. Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol. Rev. 30, 36-52 (2006
32. Li, X. Z., Zhang, L. &Nikaido, H. Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 48, 2415-2423 (2004